Pediatrix Medical Group Inc. (MD)
NYSE: MDHealth CareHospital/Nursing ManagementUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.36B
- P/E (TTM)
- 16.51
- Forward P/E
- 12.05
- EPS (TTM)
- $1.83
- Dividend yield
- None
- 52-week range
- 17.23 – 33.74
- Day range
- 29.89 – 30.43
- Volume / Avg
- 790.97K / 709.48K
- Beta
- —
- Shares outstanding
- 78.12M
52-week range
MD stock today
On Nov 20, MD ended the session at $30.22, adding $0.28 (0.94%), versus the S&P 500's 3.70% decline. Shares are 10.4% below their 52-week high of $33.74, set on Nov 5, 2026 and 75.4% above the 52-week low of $17.23, in the middle of the past year's range. MD is up 41.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 30.8%.
At 16.5x trailing earnings, Pediatrix Medical Group trades in line with the peer-group median of 16.7x. Its forward P/E of 12.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Pediatrix Medical Group
Company profilePediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program.
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- CEO
- Mr. Mark S. Ordan
- Headquarters
- Sunrise, FL
- Employees
- 4,280
- Website
- pediatrix.com
Financial highlights
Full financialsIn fiscal 2025, Pediatrix Medical Group generated $1.91 billion in revenue, down 4.9% from fiscal 2024, its first annual decline since 2020. Net income was $165.4 million, for a net margin of 8.6% versus a median of -3.0% in the prior 5 years. Operating margin was 10.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.91B | $2.01B | $1.99B | $1.97B | $1.91B |
| Growth | -4.92% | +0.92% | +1.15% | +3.18% | +10.22% |
| Net income | $165.39M | $-99.07M | $-60.41M | $66.33M | $130.96M |
| EPS (diluted) | $1.94 | $-1.19 | $-0.73 | $0.79 | $1.53 |
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$30.08-0.46%
- Strong buy 0
- Buy 1
- Hold 5
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $0.59 vs $0.59
- Surprise
- 0.00%
MD news
All MD news- Encompass Health Stock Rallies 34% YTD: Is There More Upside Ahead?NasdaqEHC, MD, CHE, ENSG
- Midland débute un programme de forage sur son projet aurifère Héva en AbitibiGlobeNewswire
- Midland Begins a Drilling Program on Its Heva Gold Project in AbitibiGlobeNewswire
- MDT Q2 Earnings Preview: Will Cardiovascular Performance Lift Results?NasdaqMDT, MD, BTSG, CON
- Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue?NasdaqVTRS, MD
- Midland, in Partnership With Fresnillo, Commences an Airborne Gravity Gradiometer Survey on the La Peltrie ProjectGlobeNewswire
- Midland, en partenariat avec Fresnillo, commence un levé de gradiométrie gravitaire aéroportée sur son projet La PeltrieGlobeNewswire
- Pediatrix Medical Group Consensus Price Target Increased by 10.13% to $29.58Nasdaq
Pediatrix Medical Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BKDBrookdale Senior Living Inc. | 8.86 | +1.96% | $2.12B | vs MD |
| ARDTArdent Health Inc. | 15.08 | +4.00% | $2.10B | vs MD |
| NHCNational HealthCare Corporation | 190.77 | +1.18% | $2.99B | vs MD |
| HCSGHealthcare Services Group Inc. | 24.72 | -0.20% | $1.67B | vs MD |
| SNDASonida Senior Living Inc. | 31.47 | -0.57% | $1.55B | vs MD |
| SGRYSurgery Partners Inc. | 26.78 | +0.34% | $3.50B | vs MD |
| CYHCommunity Health Systems Inc. | 1.62 | +0.62% | $228.46M | vs MD |
| PACSPACS Group Inc. | 43.67 | +1.49% | $6.93B | vs MD |
Indexes, lists and sector
Pediatrix Medical Group stock FAQ
What is Pediatrix Medical Group's stock price today?
MD last traded at $30.22 as of Nov 20, 4:00 PM EST, up 0.94% on the day. Prices are delayed at least 15 minutes.
Does Pediatrix Medical Group pay a dividend?
No. Pediatrix Medical Group does not currently pay a regular cash dividend.
What is MD's P/E ratio?
MD trades at a trailing P/E ratio of 16.51 and a forward P/E of 12.05, compared with a median of 16.7 for its closest peers.
Who is Pediatrix Medical Group's CEO?
Mr. Mark S. Ordan is the chief executive officer of Pediatrix Medical Group Inc., which has about 4,280 employees.
Has MD ever split its stock?
Yes. The most recent MD stock split was a 2-for-1 split on Dec 20, 2013, one of 2 splits on record.
What is the MD 52-week high?
The 52-week high for MD is $33.74 and the 52-week low is $17.23. The stock is currently 10.4% below its high.